InsiderSignal.AI

InsiderSignal.ai

AORT - Artivion, Inc.

Insider Sale by Mackin James P (Pres, CEO)

1 Month
After Trade
Before Trade

Loading data...

Trade Summary

2 days ago, Mackin James P, serving as Pres, CEO at Artivion, Inc. (AORT), sold 17,887 shares at $37.78 per share, for a total transaction value of $675,692.00. Following this transaction, Mackin James P now holds 947,275 shares of AORT.

This sale represents a 2.00% decrease in Mackin James P's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Tuesday, March 3, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, March 4, 2026, 1 day after the trade was made.

Artivion, Inc. operates in the HEALTHCARE sector, specifically within the MEDICAL DEVICES industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.

Mackin James P

Pres, CEO

J. Patrick Mackin, also known as James P. Mackin or Pat Mackin, is the President, CEO, and Chairman of Artivion, Inc. (AORT), a medical device company focused on cardiac and vascular surgery, including treatments for aortic diseases.[[1]](https://artivion.com/board-of-directors/)[[3]](https://www.gurufocus.com/insider/75932/james-p-mackin)[[4]](https://www.route92medical.com/route-92-medical-appoints-medtech-industry-leader-pat-mackin-to-its-board-of-directors/)[[5]](https://artivion.com/about/) He assumed the role of President and CEO in September 2014, joined the Board of Directors in October 2014, and became Chairman in May 2015.[[1]](https://artivion.com/board-of-directors/)[[2]](https://portersfiveforce.com/blogs/owners/artivion) Mackin brings over 30 years of experience in the medical device industry, previously serving as President of Cardiac Rhythm Disease Management at Medtronic, Inc., Vice President of Vascular for Western Europe, and Vice President and General Manager of the Endovascular Business Unit.[[1]](https://artivion.com/board-of-directors/)[[4]](https://www.route92medical.com/route-92-medical-appoints-medtech-industry-leader-pat-mackin-to-its-board-of-directors/) Earlier, he was Senior Vice President and General Manager of the Cardiovascular Surgery Business Unit at Genzyme, Inc., held various roles at Deknatel/Snowden-Pencer, Inc., and served as a First Lieutenant in the U.S. Army.[[1]](https://artivion.com/board-of-directors/) He holds a Bachelor of Science in engineering from the United States Military Academy at West Point and an MBA from Northwestern University’s Kellogg Graduate School of Management.[[1]](https://artivion.com/board-of-directors/)[[4]](https://www.route92medical.com/route-92-medical-appoints-medtech-industry-leader-pat-mackin-to-its-board-of-directors/) Mackin has also served on the boards of Route 92 Medical, Wright Medical Group (acquired by Stryker), and Opsens Medical (acquired by Haemonetics).[[3]](https://www.gurufocus.com/insider/75932/james-p-mackin)[[4]](https://www.route92medical.com/route-92-medical-appoints-medtech-industry-leader-pat-mackin-to-its-board-of-directors/)

View full insider profile →

Trade Price

$37.78

Quantity

17,887

Total Value

$675,692.00

Shares Owned

947,275

Trade Date

Tuesday, March 3, 2026

2 days ago

SEC Filing Date

Wednesday, March 4, 2026

Filed 1 day after trade

HEALTHCAREMEDICAL DEVICES

About Artivion, Inc.

Company Overview

No company information available
View news mentioning AORT

💬 Want Deeper Insight?

Use our AI assistant to ask questions about this trade, the insider, or the company.

Chat with AI

Share this trade

https://insidersignal.ai/trade/4499556

🚀 Track Insider Trades in Real-Time

Create a free account to access our full database of insider trades, AI-powered analysis, price alerts, and discover what corporate executives are buying and selling.

Create Free AccountLearn More

✓ Free forever plan available  •  ✓ No credit card required  •  ✓ Cancel anytime